Website of the Department of Health
Please note that this website has a UK government access keys system.
Page menu
Home
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
- Advisory Committee on Clinical Excellence Awards (ACCEA)
- Advisory Committee on Dangerous Pathogens (ACDP)
- Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO)
- Advisory Group on Hepatitis (AGH)
- Committee on the Medical Effects of Air Pollutants (COMEAP)
- Expert Advisory Group on AIDS (EAGA)
- Genetics and Insurance Committee (GAIC)
- Gene Therapy Advisory Committee (GTAC)
- Joint Committee on Vaccination and Immunisation (JCVI)
- Ministerial Medical Technology Strategy Group (MMTSG)
- National Blood Transfusion Committee (NBTC)
- National Clinical Audit Advisory Group (NCAAG)
- National Expert Panel on New and Emerging Infections (NEPNEI)
- Patient Information Advisory Group (PIAG)
- Scientific Pandemic Influenza Advisory Committee (SPI)
- Scientific Committee on Tobacco and Health (SCOTH)
- Standing Commission on Carers (SCOC)
- UK Stem Cell Initiative (UKSCI)
- Archive
- Advanced search
- Search results
- Help
- RSS Library
- Terms and conditions
- Site map
You are here:
National Expert Panel on New and Emerging Infections
The Chief Medical Officer's Infectious Disease Strategy - "Getting Ahead of the Curve" proposed the establishment of a National Expert Panel to assess the threat from new and emerging infectious diseases. It was envisaged that this would be an over-arching horizon scanning panel, reporting to the Chief Medical Officer and advising the Department of Health.
Terms of reference
The Panel's Terms of Reference are:
to identify key areas for action and to advise on priorities by:
- identifying emerging and potential infectious threats to public health both nationally and internationally;
- placing emerging infections in the wider clinical and public health contexts;
- advising on prevention and control measures;
- prioritising areas for surveillance and for information needs;
- advising on research, including technological development needs.
Membership
The membership includes the chairs of relevant infection-related, independent expert advisory committees, plus other relevant experts, including representation from WHO. Representatives of the Department, the HPA and a number of other government departments attend as non-members.
Meetings
Two meetings are held each year: the first was held on 25 November 2003.
Contact
NEPNEI Secretariat
Emerging Infections and Zoonoses
Health Protection Agency
61 Colindale Avenue
London NW9 5EQ
Global links
Access keys
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
- Scientific Committee on Tobacco and Health (SCOTH)
- Joint Committee on Vaccination and Immunisation (JCVI)
- Advisory Committee on Dangerous Pathogens (ACDP)
- Advisory Committee on Clinical Excellence Awards (ACCEA)
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
